Proposed Data Collection Submitted for Public Comment and Recommendations, 46852-46854 [2021-17863]
Download as PDF
<![CDATA[
46852
Federal Register / Vol. 86, No. 159 / Friday, August 20, 2021 / Notices
time points: Pre (before the training),
post (after the training), and follow-up
(4–6 weeks after the training). The
survey will assess; (1) foundational OSH
knowledge; (2) OSH attitudes; (3) selfefficacy for OSH; (4) behavioral
intention to use newly learned OSH
skills; (5) OSH training perceptions; and
(6) job safety perceptions. Basic
demographics and work experience
information will also be collected from
field pilot participants, but no sensitive
or personally identifiable information
(PII) will be collected by NIOSH.
Participants in the training group will
be asked to provide reactions to the
training during brief post-training
feedback sessions, and this data will be
workforce development program
participants, and the two trained
PacMtn WDC will conduct post-training
feedback sessions with the 36 training
group participants after each training
session. Each survey will take
approximately 30 minutes to complete,
for a total of 90 minutes per participant
to complete all three surveys. The
training will take three hours and 20
minutes to administer, and the post
training feedback session will take 10
minutes to complete.
CDC requests approval for an
estimated 43 annual burden hours.
There are no costs to respondents other
than their time to participate.
audio recorded. This field pilot will
follow the CDC COVID–19 interim
guidance for research activities,
including in-person activities, in place
at the time of the activity. This data
collection will serve as a first step in
addressing the need for evidence-based,
foundational OSH training programs for
the workforce development sector, and
is aligned with the National
Occupational Research Agenda (NORA)
Healthy Work Design and Well-Being,
Services, and Manufacturing goals
related to promoting OSH among
contingent workers.
As part of the proposed field pilot,
NIOSH will administer three online
surveys (pre, post, and follow-up) to 72
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Workforce
Workforce
Workforce
Workforce
development
development
development
development
program
program
program
program
participant
participant
participant
participant
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
.......
.......
.......
.......
Pre-survey ....................
Post-survey ...................
Follow-up Survey ..........
Post training feedback
session.
34
29
15
18
1
1
1
1
30/60
30/60
30/60
10/60
17
15
8
3
Total ...............................................................
.......................................
........................
........................
........................
43
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–17864 Filed 8–19–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[60Day–21–21HI; Docket No. CDC–2021–
0086]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
SUMMARY:
VerDate Sep<11>2014
17:27 Aug 19, 2021
Jkt 253001
proposed information collection project
titled Red Carpet Entry (RCE) Program
Implementation Project. This study will
prepare for, implement, and evaluate an
implementation model of linkage and
reengagement to HIV care via a toolkit.
DATES: CDC must receive written
comments on or before October 19,
2021.
You may submit comments,
identified by Docket No. CDC–2021–
0086 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
ADDRESSES:
Centers for Disease Control and
Prevention
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Form name
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road, NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
E:\FR\FM\20AUN1.SGM
20AUN1
46853
Federal Register / Vol. 86, No. 159 / Friday, August 20, 2021 / Notices
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Red Carpet Entry (RCE) Program
Implementation Project—New—
National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
This project involves original,
implementation research on the Red
Carpet Entry (RCE) Program to link
persons with HIV to care within 72
hours of their diagnosis or their return
to care after being out of care. Originally
developed and implemented in
Washington DC by Whitman Walker
Health and the DC Department of
Health’s HIV/AIDS, Hepatitis, STD, and
TB Administration, Red Carpet Entry
(RCE) has been shown to successfully
and rapidly link people who tested HIV
positive to an HIV care provider.
Evaluations of RCE found that 70% of
newly diagnosed people were linked to
care within 72 hours of their HIV test.
It was also shown to work for linking
people who had fallen out of care with
an HIV provider. An adapted version of
RCE has also been shown to improve
health outcomes among adolescents and
youths in Kenya by quickly linking to
care. The school-based program
increased rates of linkage to care from
56.5% to 97.3% and three-month
retention in care from 66.0% to 90.0%.
Based on this, the CDC identified RCE
as an evidence-informed structural
intervention and included it in CDC’s
Compendium of Evidence-based
Interventions (EBIs) and Best Practices
for HIV Prevention.
Having an evidence-informed
intervention like RCE that can be
disseminated to the broader HIV health
care community is important for several
reasons: (1) Antiretroviral therapy (ART)
is the best way to manage HIV and
reduce transmission; (2) ART initiation
is only possible when someone enters
health care and then is ultimately
retained in care; and (3) there are few
existing evidenced-based structural
interventions to support this process.
This bias in the field of HIV
interventions stems from a focus on
individual behavior change
interventions to prevent HIV infection.
However, as new and effective
treatments have emerged that reduce the
likelihood of HIV transmission, HIV
clinics and other healthcare settings
have emerged as key contexts for HIV
prevention by making sure that Persons
with HIV (PWH) have immediate access
to ART. Therefore, the field has slowly
shifted to understanding how providers
and health systems can be encouraged
to support PWH to reduce HIV.
This study will contribute to the field
by creating tools to support clinics and
healthcare settings that want to
implement the RCE Program to link
PWH to care. A toolkit will be created
and tested via implementing RCE in two
clinics. Lessons from the
implementation of RCE will be used to
update the toolkit. The final toolkit will
be disseminated via CDC’s website.
Furthermore, because the study also
evaluates the implementation strategies,
outcomes, and context when RCE is
being used, the study will be able to
recommend what is needed to
implement RCE with fidelity and
success and incorporate these insights
into the toolkit. Finally, because
tracking costs are also a part of the
evaluation, clinics and health systems
that are examining potential RCE
adoption will have material information
about what is needed to put RCE into
practice. An understanding of the actual
costs can provide important justification
for program planners.
The results of this study will help
CDC frame how best to disseminate the
RCE Program to the broader HIV health
care community. This is important
because only federal agencies like CDC
have the resources and infrastructure to
broadly disseminate EBIs. Broad
dissemination and uptake of EBIs like
RCE can help move population rates of
HIV suppression which would affect
population transmission rates. Linkage
to care, in an era of biomedical HIV
prevention, is a prevention linchpin.
CDC requests approval for an estimated
125 annual burden hours. There are no
costs to respondents other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses
per
respondent
Average
burden per
response
(in hours)
Total burden
hours
Form name
RCE Clients ...........................
RCE Implementation Staff ....
RCE Implementation Staff ....
Screener ...............................................................
Staff Survey—Preparation Phase ........................
Staff Survey—Implementation Phase (months
1,3,5).
Staff Survey—Implementation Phase (months
2,4,6).
Staff Interview Guide—Preparation Phase ..........
Staff Interview Guide–Implementation Phase
(months 1,3,5).
Staff Interview Guide–Implementation Phase
(months 2,4,6).
Clinic Leadership Interview Guide .......................
Labor Cost Questionnaire ....................................
Non-Labor Cost Questionnaire ............................
180
8
8
1
1
3
5/60
15/60
15/60
15
2
6
8
3
15/60
6
8
8
1
3
1
30/60
8
12
8
3
30/60
12
2
6
2
1
4
9
30/60
1.5
1.5
1
36
27
..............................................................................
......................
......................
......................
125
RCE Implementation Staff ....
RCE Implementation Staff ....
RCE Implementation Staff ....
RCE Implementation Staff ....
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Type of respondents
Clinic Leadership ...................
Total ...............................
VerDate Sep<11>2014
17:27 Aug 19, 2021
Jkt 253001
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
E:\FR\FM\20AUN1.SGM
20AUN1
46854
Federal Register / Vol. 86, No. 159 / Friday, August 20, 2021 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–17863 Filed 8–19–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10280, CMS–
1557 and CMS–3070G–I]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
October 19, 2021.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:27 Aug 19, 2021
Jkt 253001
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10280 Home Health Change of
Care Notice
CMS–1557 Survey Report Form for
Clinical Laboratory Improvement
Amendments (CLIA) and Supporting
Regulations
CMS–3070G–I ICF/IID Survey Report
Form and Supporting Regulations
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of the
Information Collection: Home Health
Change of Care Notice; Use: The
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
purpose of the Home Health Change of
Care Notice (HHCCN) is to notify
original Medicare beneficiaries
receiving home health care benefits of
plan of care changes. Home health
agencies (HHAs) are required to provide
written notice to Original Medicare
beneficiaries under various
circumstances involving the reduction
or termination of items and/or services
consistent with Home Health Agencies
Conditions of Participation (COPs).
The home health COP requirements
are set forth in § 1891[42 U.S.C.
1395bbb] of the Social Security Act (the
Act). The implementing regulations
under 42 CFR 484.10(c) specify that
Medicare patients receiving HHA
services have rights. The patient has the
right to be informed, in advance about
the care to be furnished, and of any
changes in the care to be furnished. The
HHA must advise the patient in advance
of the disciplines that will furnish care,
and the frequency of visits proposed to
be furnished. The HHA must advise the
patient in advance of any change in the
plan of care before the change is made.’’
Notification is required for covered
and non-covered services listed in the
plan of care (POC). The beneficiary will
use the information provided to decide
whether or not to pursue alternative
options to continue receiving the care
noted on the HHCCN. Form Number:
CMS–10280 (OMB control number:
0938–1196); Frequency: Yearly; Affected
Public: Private Sector (Business or other
for-profits, Not-for-Profit Institutions);
Number of Respondents: 11,157; Total
Annual Responses: 12,385,108; Total
Annual Hours: 824,848. (For policy
questions regarding this collection
contact Jennifer McCormick at 410–786–
2852.)
2. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Survey Report
Form for Clinical Laboratory
Improvement Amendments (CLIA) and
Supporting Regulations; Use: The form
is used to report surveyor findings
during a CLIA survey. For each type of
survey conducted (i.e., initial
certification, recertification, validation,
complaint, addition/deletion of
specialty/subspecialty, transfusion
fatality investigation, or revisit
inspections) the Survey Report Form
incorporates the requirements specified
in the CLIA regulations. Form Number:
CMS–1557 (OMB control number:
0938–0544); Frequency: Biennially;
Affected Public: Private sector (Business
or other for-profit and Not-for-profit
institutions, State, Local or Tribal
Governments and Federal Government);
Number of Respondents: 15,975; Total
E:\FR\FM\20AUN1.SGM
20AUN1
]]>Agencies
[Federal Register Volume 86, Number 159 (Friday, August 20, 2021)]
[Notices]
[Pages 46852-46854]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17863]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-21HI; Docket No. CDC-2021-0086]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Red Carpet Entry (RCE) Program
Implementation Project. This study will prepare for, implement, and
evaluate an implementation model of linkage and reengagement to HIV
care via a toolkit.
DATES: CDC must receive written comments on or before October 19, 2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0086 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road, NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7118; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the
[[Page 46853]]
proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Red Carpet Entry (RCE) Program Implementation Project--New--
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
This project involves original, implementation research on the Red
Carpet Entry (RCE) Program to link persons with HIV to care within 72
hours of their diagnosis or their return to care after being out of
care. Originally developed and implemented in Washington DC by Whitman
Walker Health and the DC Department of Health's HIV/AIDS, Hepatitis,
STD, and TB Administration, Red Carpet Entry (RCE) has been shown to
successfully and rapidly link people who tested HIV positive to an HIV
care provider. Evaluations of RCE found that 70% of newly diagnosed
people were linked to care within 72 hours of their HIV test. It was
also shown to work for linking people who had fallen out of care with
an HIV provider. An adapted version of RCE has also been shown to
improve health outcomes among adolescents and youths in Kenya by
quickly linking to care. The school-based program increased rates of
linkage to care from 56.5% to 97.3% and three-month retention in care
from 66.0% to 90.0%. Based on this, the CDC identified RCE as an
evidence-informed structural intervention and included it in CDC's
Compendium of Evidence-based Interventions (EBIs) and Best Practices
for HIV Prevention.
Having an evidence-informed intervention like RCE that can be
disseminated to the broader HIV health care community is important for
several reasons: (1) Antiretroviral therapy (ART) is the best way to
manage HIV and reduce transmission; (2) ART initiation is only possible
when someone enters health care and then is ultimately retained in
care; and (3) there are few existing evidenced-based structural
interventions to support this process. This bias in the field of HIV
interventions stems from a focus on individual behavior change
interventions to prevent HIV infection. However, as new and effective
treatments have emerged that reduce the likelihood of HIV transmission,
HIV clinics and other healthcare settings have emerged as key contexts
for HIV prevention by making sure that Persons with HIV (PWH) have
immediate access to ART. Therefore, the field has slowly shifted to
understanding how providers and health systems can be encouraged to
support PWH to reduce HIV.
This study will contribute to the field by creating tools to
support clinics and healthcare settings that want to implement the RCE
Program to link PWH to care. A toolkit will be created and tested via
implementing RCE in two clinics. Lessons from the implementation of RCE
will be used to update the toolkit. The final toolkit will be
disseminated via CDC's website. Furthermore, because the study also
evaluates the implementation strategies, outcomes, and context when RCE
is being used, the study will be able to recommend what is needed to
implement RCE with fidelity and success and incorporate these insights
into the toolkit. Finally, because tracking costs are also a part of
the evaluation, clinics and health systems that are examining potential
RCE adoption will have material information about what is needed to put
RCE into practice. An understanding of the actual costs can provide
important justification for program planners.
The results of this study will help CDC frame how best to
disseminate the RCE Program to the broader HIV health care community.
This is important because only federal agencies like CDC have the
resources and infrastructure to broadly disseminate EBIs. Broad
dissemination and uptake of EBIs like RCE can help move population
rates of HIV suppression which would affect population transmission
rates. Linkage to care, in an era of biomedical HIV prevention, is a
prevention linchpin. CDC requests approval for an estimated 125 annual
burden hours. There are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average
Number of responses burden per Total burden
Type of respondents Form name respondents per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
RCE Clients....................... Screener............ 180 1 5/60 15
RCE Implementation Staff.......... Staff Survey-- 8 1 15/60 2
Preparation Phase.
RCE Implementation Staff.......... Staff Survey-- 8 3 15/60 6
Implementation
Phase (months
1,3,5).
RCE Implementation Staff.......... Staff Survey-- 8 3 15/60 6
Implementation
Phase (months
2,4,6).
RCE Implementation Staff.......... Staff Interview 8 1 1 8
Guide--Preparation
Phase.
RCE Implementation Staff.......... Staff Interview 8 3 30/60 12
Guide-Implementatio
n Phase (months
1,3,5).
RCE Implementation Staff.......... Staff Interview 8 3 30/60 12
Guide-Implementatio
n Phase (months
2,4,6).
Clinic Leadership................. Clinic Leadership 2 1 30/60 1
Interview Guide.
Labor Cost 6 4 1.5 36
Questionnaire.
Non-Labor Cost 2 9 1.5 27
Questionnaire.
-------------------------------------------------------
Total......................... .................... ............ ............ ............ 125
----------------------------------------------------------------------------------------------------------------
[[Page 46854]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-17863 Filed 8-19-21; 8:45 am]
BILLING CODE 4163-18-P
